These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34215321)

  • 21. CCR2-engineered mesenchymal stromal cells accelerate diabetic wound healing by restoring immunological homeostasis.
    Kuang S; He F; Liu G; Sun X; Dai J; Chi A; Tang Y; Li Z; Gao Y; Deng C; Lin Z; Xiao H; Zhang M
    Biomaterials; 2021 Aug; 275():120963. PubMed ID: 34153785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
    Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
    Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation.
    Huang Y; Wang J; Cai J; Qiu Y; Zheng H; Lai X; Sui X; Wang Y; Lu Q; Zhang Y; Yuan M; Gong J; Cai W; Liu X; Shan Y; Deng Z; Shi Y; Shu Y; Zhang L; Qiu W; Peng L; Ren J; Lu Z; Xiang AP
    Theranostics; 2018; 8(21):5929-5944. PubMed ID: 30613272
    [No Abstract]   [Full Text] [Related]  

  • 24. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.
    Rafei M; Campeau PM; Aguilar-Mahecha A; Buchanan M; Williams P; Birman E; Yuan S; Young YK; Boivin MN; Forner K; Basik M; Galipeau J
    J Immunol; 2009 May; 182(10):5994-6002. PubMed ID: 19414750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.
    Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK
    Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemokine receptor CCR2 maintains plasmacytoid dendritic cell homeostasis.
    Cédile O; Jørgensen LØ; Frank I; Wlodarczyk A; Owens T
    Immunol Lett; 2017 Dec; 192():72-78. PubMed ID: 29106985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.
    Rafei M; Hsieh J; Fortier S; Li M; Yuan S; Birman E; Forner K; Boivin MN; Doody K; Tremblay M; Annabi B; Galipeau J
    Blood; 2008 Dec; 112(13):4991-8. PubMed ID: 18812467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
    Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
    Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperocclusion up-regulates CCL3 expression in CCL2- and CCR2-deficient mice.
    Tsutsumi T; Kajiya H; Goto KT; Takahashi Y; Okabe K
    J Dent Res; 2013 Jan; 92(1):65-70. PubMed ID: 23143790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms.
    Lee HK; Kim HS; Kim JS; Kim YG; Park KH; Lee JH; Kim KH; Chang IY; Bae SC; Kim Y; Hong JT; Kehrl JH; Han SB
    Sci Rep; 2017 Jan; 7():41258. PubMed ID: 28117437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension.
    Suzuki T; Sato Y; Yamamoto H; Kato T; Kitase Y; Ueda K; Mimatsu H; Sugiyama Y; Onoda A; Saito S; Takahashi Y; Nakayama T; Hayakawa M
    Cytotherapy; 2020 Apr; 22(4):180-192. PubMed ID: 32139242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL2 mediates anti-fibrotic effects in human fibroblasts independently of CCR2.
    Kalderén C; Stadler C; Forsgren M; Kvastad L; Johansson E; Sydow-Bäckman M; Svensson Gelius S
    Int Immunopharmacol; 2014 May; 20(1):66-73. PubMed ID: 24583146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
    Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
    J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C5a enhances Vδ1 T cells recruitment via the CCL2-CCR2 axis in IgA nephropathy.
    Deng S; Zhou F; Wang F; Jiang Y; Tang J; Hu X; Luo L; Jin Y; Huang L; Sun D; Xiao G; Feng J; Li X
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111065. PubMed ID: 37862725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain.
    Andres RH; Choi R; Pendharkar AV; Gaeta X; Wang N; Nathan JK; Chua JY; Lee SW; Palmer TD; Steinberg GK; Guzman R
    Stroke; 2011 Oct; 42(10):2923-31. PubMed ID: 21836091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity.
    Traynor TR; Herring AC; Dorf ME; Kuziel WA; Toews GB; Huffnagle GB
    J Immunol; 2002 May; 168(9):4659-66. PubMed ID: 11971015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL2 recruits T cells into the brain in a CCR2-independent manner.
    Cédile O; Wlodarczyk A; Owens T
    APMIS; 2017 Nov; 125(11):945-956. PubMed ID: 28836736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Mesenchymal Stem Cells and Imatinib in the Process of Liver Fibrosis Healing Through
    Varjavand P; Hesampour A
    Rep Biochem Mol Biol; 2023 Jul; 12(2):350-358. PubMed ID: 38317807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.